25 results
424B5
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Prospectus supplement for primary offering
5:16pm
requirement that has or may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement
6-K
EX-1.1
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Report of Foreign Private Issuer
4:46pm
Company Accounting Oversight Board (“PCAOB”). The summary and selected consolidated financial and statistical data included or incorporated by reference … of the Securities Act and the Public Company Accounting Oversight Board, (ii) stating, as of such date, the conclusions and findings of such firm with respect
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
23 Aug 23
Tiziana Life Sciences Announces Appointment of William A. Clementi as Chief Development Officer
10:30am
and device-drug products. Clementi Ltd also provides high-level cGMP and GCP oversight.
Dr. Clementi is a graduate of Boston University and the University
20-F/A
2022 FY
TLSA
Tiziana Life Sciences Ltd
13 Jun 23
Annual report (foreign) (amended)
12:37pm
Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S … Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Group in accordance with the U.S. federal
F-3
n2dmfzhl1sb3rau
26 Jan 21
Shelf registration (foreign)
5:31pm
6-K
EX-99.2
9sku7 oyp
16 Sep 20
Tiziana Life Sciences Announces Planned Spin Out of StemPrintER into a New Publicly Listed Company, AccuStem Sciences
6:04am
6-K
EX-1.1
l2pv8h
14 Apr 20
Current report (foreign)
8:46am
F-1/A
8e4mohc3 o6
20 Sep 19
Registration statement (foreign) (amended)
4:51pm
F-1/A
fc05g9t
17 Sep 19
Registration statement (foreign) (amended)
5:19pm
F-1
ufbypstz2ljuzl
5 Aug 19
Registration statement (foreign)
4:28pm
F-1
EX-1.1
at63z4u
5 Aug 19
Registration statement (foreign)
4:28pm
DRS
EX-1.1
83b5ru6 v9xhp
17 Jul 19
Draft registration statement
12:00am
DRS
5ef16jucqnd6
17 Jul 19
Draft registration statement
12:00am
20-F
0t0quedyal 2q0nkfr
4 Apr 19
Annual report (foreign)
6:07am
424B4
goi2slbabjqon
21 Nov 18
Prospectus supplement with pricing info
6:10am
POS AM
wpi65k4
14 Nov 18
Prospectus update (post-effective amendment)
12:00am